Dallas-based Secretome Therapeutics announced that Deepa Prasad has been appointed chief financial officer of the biotechnology company, which develops first-in-class therapeutics derived from neonatal mesenchymal stem cells for the treatment of underserved diseases.
“Deepa brings a wealth of knowledge through her combination of investment banking, operations, and venture capital experience in the life science industry,” Vinny Jindal, president and chief executive officer of Secretome Therapeutics, said in a statement....




![Jeb Hensarling [Photo: Grant Miller Photograhy/Venture Dallas]](https://s24806.pcdn.co/wp-content/uploads/2025/11/20251030VentureDallasConference-DSC_6240.jpg)
![An MK30 drone on a landing pad. Amazon began commercial drone service with the MK30 in College Station, Texas, and the Phoenix metro area in November 2024. [Photo: Amazon]](https://s24806.pcdn.co/wp-content/uploads/2026/04/Amazon-MK30-drone.jpg)

